ETF Components for PID - PowerShares Intl Dividend Achievers


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
BTI A 1.09 4.14
AY B 0.69 4.06
NGG D 2.91 3.98
PHI C 1.05 3.89
TD F 0.76 3.69
SNY B 0.66 2.92
NVS A 0.32 2.68
INFY B 0.73 2.62
OTEX D 1.50 2.50
DEO F 1.70 2.00
SMFG A -0.29 1.93
KOF F 2.82 1.76
GFI D 2.34 1.74
PSO B 0.97 1.73
MUFG A -0.80 1.65
DOX D -1.62 1.60
RELX B 0.42 1.26
CNI D 1.28 1.24
RBA B 1.10 1.13
SAP A 2.24 1.03
WTW B -0.67 0.99
LOGI C 0.89 0.80
NVO C -2.87 0.77
WCN A 1.41 0.52

Recent News for PowerShares Intl Dividend Achievers & its Holdings

Date Stock Title
Jul 3 NVO S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 NVO Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
Jul 3 NVO Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
Jul 3 NVO Weight-loss drugs linked to rare vision loss: Harvard study
Jul 3 NVO Update: Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
Jul 3 NVO Novo Nordisk’s Ozempic, Wegovy linked to eye disorder in small study
Jul 3 NVO Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
Jul 3 NVO Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
Jul 3 SNY Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
Jul 3 OTEX Open Text plans to cut ~1,200 positions
Jul 3 SNY Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3 NVO Should You Hold Novo Nordisk A/S (NVO) for the Long Term?
Jul 3 SNY Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Jul 3 SNY Sanofi, Regeneron win EU label expansion for Dupixent in COPD
Jul 3 MUFG MUFG’s Talks for Stake in India Consumer Lender Said to Hit Snag
Jul 3 SNY EMA approves Sanofi’s Dupixent for COPD treatment in adults
Jul 3 DEO Dow Futures Edge Higher; Treasury Yields Little Changed
Jul 3 SNY Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
Jul 3 BTI I Wouldn't Touch This Stock With a 10-Foot Pole -- Here's the High-Yield Stock I'd Buy Instead
Jul 3 LOGI Up 65% in a Year, This Pandemic Winner Could Get a Big Boost Thanks to Artificial Intelligence (AI)
The PowerShares International Dividend Achievers™ Portfolio (Fund) is based on the NASDAQ International Dividend AchieversTM Index (Index). The Fund will normally invest at least 90% of its total assets in dividend paying common stocks that comprise the Index. The Index is designed to identify an international group of American Depository Receipts, Global Depositary Receipts and non-U.S. common or ordinary stocks that have qualified as International Dividend Achievers™. These companies have increased their annual dividend for five or more consecutive fiscal years. The Fund and the Index are reconstituted annually in January and rebalanced quarterly in January, April, July and October. Effective December 28, 2012, the NADAQ OMX Group, Inc., replaced Mergent, Inc., as the Index Provider of the Index. Effective February 25, 2013, the name of the Index changed from International Dividend Achievers Index to NASDAQ International Dividend Achievers Index. There will be no change to the methodology by which NASDAQ OMX Group, Inc., the Index Provider, calculates the Index. Please see the Fund’s prospectus supplement for more information. On February 25, 2013, NASDAQ took the place of the NYSE as the official Index data source.
Exchange Traded Fund ETF Stock Market Index Dividend Nasdaq 100 Invesco Powershares American Depositary Receipt Nasdaq Composite Index Nasdaq Internet Index
Back to the Main PID Page...